MedTrace Logo

Prometra's Utilization in Mitigating Pain II

NCT00866164 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2012-03-05

No results posted yet for this study

Summary

Intrathecal infusion pumps are increasingly used to deliver analgesics for chronic intractable pain. The PUMP II trial is designed to evaluate the ongoing safety and efficacy of the new Prometra® Programmable Pump System for intrathecal administration of morphine sulfate to treat chronic intractable pain.

Conditions

  • Intractable Pain
  • Back Pain
  • Leg Pain
  • Arm Pain
  • Trunk Pain

Interventions

DEVICE

Prometra Programmable Pump

Implantation of Prometra Pump for delivery of intrathecal morphine for the treatment of chronic intractable pain

Sponsors & Collaborators

  • Flowonix Medical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00866164 on ClinicalTrials.gov